Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01362179 · ClinicalTrials.gov registry record
National Marrow Donor Program Long-Term Donor Follow-Up
A clinical trial, sponsored by Center for International Blood and Marrow Transplant Research.
- Completed
- Registry status
- 21,974
- Enrollment target
NCT01362179: Completed study, sponsored by Center for International Blood and Marrow Transplant Research.
NCT01362179 is a clinical trial that has completed, run by Center for International Blood and Marrow Transplant Research. The registered enrollment target is 21,974 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01362179 has completed, sponsored by Center for International Blood and Marrow Transplant Research.
- COMPLETED
- Registry status
- 21,974 participants
- Enrollment target
Study Summary
This is an observational study of unstimulated bone marrow (BM) and filgrastim-mobilized peripheral blood stem cell (PBSC) donors. The primary goal is to evaluate the hypothesis that the incidence of targeted malignant, thrombotic and autoimmune disorders after unrelated hematopoietic stem cell donation are similar between unstimulated BM and filgrastim-mobilized PBSC donors.
Primary Outcome
To describe the long-term incidence of malignant myeloid hematologic disorders in donors who received and in those who did not receive filgrastim.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21,974 participants |
| Start Date | 2010-10 |
| Est. Completion | 2020-10-15 |
What the finished NCT01362179 record still lists
NCT01362179 is an observational study that tracks outcomes without assigning an intervention. Its 21,974 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT01362179 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01362179 about?
NCT01362179 is a clinical study titled "National Marrow Donor Program Long-Term Donor Follow-Up". This is an observational study of unstimulated bone marrow (BM) and filgrastim-mobilized peripheral blood stem cell (PBSC) donors. The primary goal is to evaluate the hypothesis that the incidence of targeted malignant, thrombotic and autoimmune disorders after unrelated hematopoietic stem cell dona...
What is the current status of trial NCT01362179?
This trial is currently completed. The enrollment target is 21,974 participants. The study started on 2010-10. Estimated completion is 2020-10-15.
Who is sponsoring clinical trial NCT01362179?
This trial is sponsored by Center for International Blood and Marrow Transplant Research, which has 29 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05832307 · 22,000 participants · NA
The INFLUENTIAL Trial- Evaluation of National Inpatient Influenza Vaccination Program
- NCT05488080 · 22,032 participants · NA
PAINED: Project Addressing INequities in the Emergency Department
- NCT07413211 · 22,068 participants
Genetic Developmental and Epileptic Encephalopathy Natural History Study for Clinical Trial Readiness
- NCT06486688 · 22,320 participants · NA
Centralized Virtual SBIRT for Pediatric Primary Care
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia